|
Experimental verification of in-silico results is pivotal. We run a wide spectrum of in-vitro and in-vivo biomarker
and target verification procedures, complemented by prototyping of diagnostic kits and therapy candidates.
Our asset in preclinics is based upon our broad development network involving prototype contract manufacturers and
clinical partners for prototype evaluation.
|
|
